<p>随着全球市场调整货币政策和持续的人工智能热潮，亚洲经济正面临一系列挑战与机遇。中国股市受到国内流动性的支撑，而日本经济则显示出增长迹象，投资者越来越关注能够在这些动态条件下蓬勃发展的中小型股票。识别有前景的公司通常需要评估其对技术进步和经济变化的适应能力，使其成为该地区潜在的 “未被发现的瑰宝”。</p>
<h3>亚洲十大基本面强劲的未被发现的瑰宝</h3>
<table>
<thead>
<tr>
<th>名称</th>
<th>负债权益比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>伊藤忠食品</td>
<td>NA</td>
<td>1.64%</td>
<td>15.30%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>许昌远东驱动轴有限公司</td>
<td>NA</td>
<td>-13.99%</td>
<td>-30.38%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>西松科技</td>
<td>NA</td>
<td>1.35%</td>
<td>-9.69%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>泰顺企业</td>
<td>0.03%</td>
<td>5.34%</td>
<td>7.18%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>深圳通业科技有限公司</td>
<td>11.85%</td>
<td>16.14%</td>
<td>-6.98%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>沈阳远大智能产业集团有限公司</td>
<td>NA</td>
<td>10.58%</td>
<td>33.69%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>东方精密与工程有限公司</td>
<td>34.33%</td>
<td>7.40%</td>
<td>2.05%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>DYPNF 有限公司</td>
<td>26.11%</td>
<td>13.24%</td>
<td>0.06%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>广东三和桩</td>
<td>75.26%</td>
<td>-3.96%</td>
<td>-36.19%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>TSTE</td>
<td>38.15%</td>
<td>4.63%</td>
<td>-6.91%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们亚洲基本面强劲的未被发现的瑰宝筛选器中的 2402 只股票的完整列表。</p>
<p>让我们深入探讨筛选器中的一些优质选择。</p>
<h2>常州朗博密封科技有限公司 (SHSE:603655)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 常州朗博密封科技有限公司 (SHSE:603655) 专注于密封产品和组件的生产，市值为 48.7 亿人民币。</p>
<p><strong>运营：</strong> 该公司主要通过制造业产生收入，金额为 2.2456 亿人民币。</p>
<p>朗博密封科技作为汽车零部件行业的灵活参与者，过去一年表现出 51.9% 的显著盈利增长，超过行业的 2.3%。2025 年上半年收入达到 1.2184 亿人民币，较去年 1.0323 亿人民币有所增长，净收入从 1204 万人民币上升至 1928 万人民币，尽管过去五年年均盈利下降 2.2%，但其似乎仍有持续增长的势头。没有负债提供了财务灵活性；然而，近期股价波动和 610 万人民币的显著一次性收益表明，未来需要谨慎监控。</p>
<ul>
<li>点击这里访问我们的完整健康分析报告，以了解常州朗博密封科技有限公司的动态。</li>
<li>了解常州朗博密封科技有限公司的历史表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aa46be72-73ba-4f36-b8ac-92e8c812f5c0/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aa46be72-73ba-4f36-b8ac-92e8c812f5c0/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 9 月的 SHSE:603655 负债权益比</p>
<h2>无锡振华汽车零部件有限公司 (SHSE:605319)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 无锡振华汽车零部件有限公司在中国制造和销售汽车零部件，市值为 92.5 亿人民币。</p>
<p><strong>运营：</strong> 该公司通过在中国制造和销售汽车零部件产生收入，市值为 92.5 亿人民币。</p>
<p>无锡振华汽车零部件作为汽车零部件行业的有前景参与者，表现稳健。过去一年，该公司的盈利增长了 22%，超过行业的 2.3%。其净负债权益比为 28.9%，利息支付由 EBIT 以 20.6 倍的覆盖率良好覆盖。最近报告的半年销售额达到 12.2 亿人民币，较去年 10.6 亿人民币有所上升，净收入为 2.01 亿人民币，较之前的 1.58 亿人民币有所增长。以仅 22 倍的市盈率相比于中国市场平均 45 倍，提供了吸引投资者在亚洲动态市场中寻求增长的价值潜力。</p>
<ul>
<li>通过阅读我们的健康报告，深入了解无锡振华汽车零部件有限公司的表现。</li>
<li>查看我们的历史表现报告，以获取无锡振华汽车零部件有限公司的过去表现的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b1d3b7a3-9d3a-41e4-a506-4a5872b1a966/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b1d3b7a3-9d3a-41e4-a506-4a5872b1a966/chart/earnings-and-revenue-growth"/></p>
<p>截至 2025 年 9 月的 SHSE:605319 盈利和收入增长</p>
<h2>毕得医药 (SHSE:688073)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 毕得医药有限公司在中国从事药品的研究、开发、生产和销售，市值为 64.5 亿人民币。</p>
<p><strong>运营：</strong> 毕得医药主要通过研究和开发行业产生收入，金额为 12 亿人民币。</p>
<p>毕得医药最近的表现突显了其在制药行业的强劲地位，过去一年盈利增长 79.1%，显著超过行业平均的-0.8%。该公司报告 2025 年上半年净收入为 7341 万人民币，较去年 5184 万人民币有所上升，同时销售额从 532.2 百万人民币上升至 627.53 百万人民币。尽管近期股价波动，毕得今年回购了价值 9999 万人民币的股份，反映出对其估值和未来前景的信心，预计年盈利增长为 21.28%。</p>
<ul>
<li>点击这里深入了解毕得医药的具体情况，查看我们的详细健康报告。</li>
<li>通过我们的历史报告获取毕得医药的过去趋势和表现的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/dd89aae6-cc4a-4bcd-a11f-dd1dfa24ee7b/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/dd89aae6-cc4a-4bcd-a11f-dd1dfa24ee7b/chart/earnings-and-revenue-growth"/></p>
<p>截至 2025 年 9 月的 SHSE:688073 盈利和收入增长</p>
<h2>抓住机会</h2>
<ul>
<li>点击此链接深入了解我们亚洲未被发现的基本面强劲的 2402 家公司。</li>
<li>这些公司中有哪一些是你资产组合的一部分吗？利用 Simply Wall St 的投资组合分析能力，全面了解它们的发展情况。</li>
<li>Simply Wall St 是你解锁全球市场趋势的关键，是一款面向前瞻性投资者的免费用户友好应用程序。</li>
</ul>
<h2>对其他可能性感兴趣吗？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实你的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑你的目标或财务状况。我们的目标是为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

无锡振华

毕得医药

<p>随着全球市场适应不断变化的货币政策和人工智能的繁荣，亚洲经济面临着挑战和机遇。投资者正将目光聚焦于小型股，特别是在中国和日本。文章强调了十家具有强大基本面的有前景的公司，包括常州朗博密封科技、无锡振华汽车零部件和毕得医药，展示了它们的财务表现和增长潜力。这些公司被视为该地区的 “未被发现的瑰宝”，吸引着寻求在动态市场中获得增长的投资者</p>

<p>As global markets adjust to shifting monetary policies and the ongoing AI boom, Asian economies are experiencing a mix of challenges and opportunities. With China's stock markets buoyed by domestic liquidity and Japan's economy showing signs of growth, investors are increasingly looking for small-cap stocks that can thrive amid these dynamic conditions. Identifying promising companies often involves assessing their adaptability to technological advancements and economic shifts, making them potential &#34;undiscovered gems&#34; in the region.</p>
<div class="lb-trans"><p>随着全球市场调整货币政策和持续的人工智能热潮，亚洲经济正面临一系列挑战与机遇。中国股市受到国内流动性的支撑，而日本经济则显示出增长迹象，投资者越来越关注能够在这些动态条件下蓬勃发展的中小型股票。识别有前景的公司通常需要评估其对技术进步和经济变化的适应能力，使其成为该地区潜在的 “未被发现的瑰宝”。</p>
</div><h3>Top 10 Undiscovered Gems With Strong Fundamentals In Asia</h3>
<div class="lb-trans"><h3>亚洲十大基本面强劲的未被发现的瑰宝</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Debt To Equity</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Health Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>ITOCHU-SHOKUHIN</td>
<td>NA</td>
<td>1.64%</td>
<td>15.30%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Xuchang Yuandong Drive ShaftLtd</td>
<td>NA</td>
<td>-13.99%</td>
<td>-30.38%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Saison Technology</td>
<td>NA</td>
<td>1.35%</td>
<td>-9.69%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Taisun Enterprise</td>
<td>0.03%</td>
<td>5.34%</td>
<td>7.18%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Shenzhen Tongye TechnologyLtd</td>
<td>11.85%</td>
<td>16.14%</td>
<td>-6.98%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Shenyang Yuanda Intellectual Industry GroupLtd</td>
<td>NA</td>
<td>10.58%</td>
<td>33.69%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Oriental Precision &amp; EngineeringLtd</td>
<td>34.33%</td>
<td>7.40%</td>
<td>2.05%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>DYPNFLtd</td>
<td>26.11%</td>
<td>13.24%</td>
<td>0.06%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Guangdong Sanhe Pile</td>
<td>75.26%</td>
<td>-3.96%</td>
<td>-36.19%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>TSTE</td>
<td>38.15%</td>
<td>4.63%</td>
<td>-6.91%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名称</th>
<th>负债权益比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>伊藤忠食品</td>
<td>NA</td>
<td>1.64%</td>
<td>15.30%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>许昌远东驱动轴有限公司</td>
<td>NA</td>
<td>-13.99%</td>
<td>-30.38%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>西松科技</td>
<td>NA</td>
<td>1.35%</td>
<td>-9.69%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>泰顺企业</td>
<td>0.03%</td>
<td>5.34%</td>
<td>7.18%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>深圳通业科技有限公司</td>
<td>11.85%</td>
<td>16.14%</td>
<td>-6.98%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>沈阳远大智能产业集团有限公司</td>
<td>NA</td>
<td>10.58%</td>
<td>33.69%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>东方精密与工程有限公司</td>
<td>34.33%</td>
<td>7.40%</td>
<td>2.05%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>DYPNF 有限公司</td>
<td>26.11%</td>
<td>13.24%</td>
<td>0.06%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>广东三和桩</td>
<td>75.26%</td>
<td>-3.96%</td>
<td>-36.19%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>TSTE</td>
<td>38.15%</td>
<td>4.63%</td>
<td>-6.91%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 2402 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener.</p>
<div class="lb-trans"><p>点击这里查看我们亚洲基本面强劲的未被发现的瑰宝筛选器中的 2402 只股票的完整列表。</p>
</div><p>Let's dive into some prime choices out of from the screener.</p>
<div class="lb-trans"><p>让我们深入探讨筛选器中的一些优质选择。</p>
</div><h2>Changzhou Langbo Sealing TechnologiesLtd (SHSE:603655)</h2>
<div class="lb-trans"><h2>常州朗博密封科技有限公司 (SHSE:603655)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Changzhou Langbo Sealing Technologies Ltd (SHSE:603655) specializes in the production of sealing products and components, with a market cap of CN¥4.87 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 常州朗博密封科技有限公司 (SHSE:603655) 专注于密封产品和组件的生产，市值为 48.7 亿人民币。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from the manufacturing industry, amounting to CN¥224.56 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过制造业产生收入，金额为 2.2456 亿人民币。</p>
</div><p>Langbo Sealing Technologies, a nimble player in the auto components sector, has demonstrated impressive earnings growth of 51.9% over the past year, outpacing the industry's 2.3%. With revenue reaching CN¥121.84 million for H1 2025, up from CN¥103.23 million last year, and net income climbing to CN¥19.28 million from CN¥12.04 million, it seems poised for continued momentum despite historical earnings decline of 2.2% annually over five years. The absence of debt offers financial flexibility; however, recent volatility in share price and a notable one-off gain of CN¥6.1M suggest careful monitoring is warranted moving forward.</p>
<div class="lb-trans"><p>朗博密封科技作为汽车零部件行业的灵活参与者，过去一年表现出 51.9% 的显著盈利增长，超过行业的 2.3%。2025 年上半年收入达到 1.2184 亿人民币，较去年 1.0323 亿人民币有所增长，净收入从 1204 万人民币上升至 1928 万人民币，尽管过去五年年均盈利下降 2.2%，但其似乎仍有持续增长的势头。没有负债提供了财务灵活性；然而，近期股价波动和 610 万人民币的显著一次性收益表明，未来需要谨慎监控。</p>
</div><ul>
<li>Click here and access our complete health analysis report to understand the dynamics of Changzhou Langbo Sealing TechnologiesLtd.</li>
<li>Learn about Changzhou Langbo Sealing TechnologiesLtd's historical performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们的完整健康分析报告，以了解常州朗博密封科技有限公司的动态。</li>
<li>了解常州朗博密封科技有限公司的历史表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aa46be72-73ba-4f36-b8ac-92e8c812f5c0/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/aa46be72-73ba-4f36-b8ac-92e8c812f5c0/chart/debt-equity-history-analysis"/></p>
<p>SHSE:603655 Debt to Equity as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 SHSE:603655 负债权益比</p>
</div><h2>Wuxi Zhenhua Auto PartsLtd (SHSE:605319)</h2>
<div class="lb-trans"><h2>无锡振华汽车零部件有限公司 (SHSE:605319)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Wuxi Zhenhua Auto Parts Co., Ltd. manufactures and sells auto parts in China with a market cap of CN¥9.25 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 无锡振华汽车零部件有限公司在中国制造和销售汽车零部件，市值为 92.5 亿人民币。</p>
</div><p><strong>Operations:</strong> The company generates revenue from manufacturing and selling auto parts in China. It has a market capitalization of CN¥9.25 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司通过在中国制造和销售汽车零部件产生收入，市值为 92.5 亿人民币。</p>
</div><p>Wuxi Zhenhua Auto Parts, a promising player in the auto components sector, has demonstrated solid performance. The company's earnings grew by 22% over the past year, outpacing the industry's 2.3%. Its net debt to equity ratio stands at a satisfactory 28.9%, with interest payments well covered by EBIT at 20.6 times coverage. Recently reported half-year sales reached CNY 1.22 billion, up from CNY 1.06 billion last year, while net income hit CNY 201 million compared to CNY 158 million previously. With a price-to-earnings ratio of just 22x against the CN market's average of 45x, it offers attractive value potential for investors seeking growth in Asia's dynamic markets.</p>
<div class="lb-trans"><p>无锡振华汽车零部件作为汽车零部件行业的有前景参与者，表现稳健。过去一年，该公司的盈利增长了 22%，超过行业的 2.3%。其净负债权益比为 28.9%，利息支付由 EBIT 以 20.6 倍的覆盖率良好覆盖。最近报告的半年销售额达到 12.2 亿人民币，较去年 10.6 亿人民币有所上升，净收入为 2.01 亿人民币，较之前的 1.58 亿人民币有所增长。以仅 22 倍的市盈率相比于中国市场平均 45 倍，提供了吸引投资者在亚洲动态市场中寻求增长的价值潜力。</p>
</div><ul>
<li>Get an in-depth perspective on Wuxi Zhenhua Auto PartsLtd's performance by reading our health report here.</li>
<li>Review our historical performance report to gain insights into Wuxi Zhenhua Auto PartsLtd's's past performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过阅读我们的健康报告，深入了解无锡振华汽车零部件有限公司的表现。</li>
<li>查看我们的历史表现报告，以获取无锡振华汽车零部件有限公司的过去表现的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b1d3b7a3-9d3a-41e4-a506-4a5872b1a966/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/b1d3b7a3-9d3a-41e4-a506-4a5872b1a966/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:605319 Earnings and Revenue Growth as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 SHSE:605319 盈利和收入增长</p>
</div><h2>Bide Pharmatech (SHSE:688073)</h2>
<div class="lb-trans"><h2>毕得医药 (SHSE:688073)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Bide Pharmatech Co., Ltd. is involved in the research, development, production, and sale of pharmaceutical products in China with a market capitalization of CN¥6.45 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 毕得医药有限公司在中国从事药品的研究、开发、生产和销售，市值为 64.5 亿人民币。</p>
</div><p><strong>Operations:</strong> Bide Pharmatech generates revenue primarily from the research and development industry, amounting to CN¥1.20 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 毕得医药主要通过研究和开发行业产生收入，金额为 12 亿人民币。</p>
</div><p>Bide Pharmatech's recent performance highlights its strong position in the pharmaceutical sector, with earnings growth of 79.1% over the past year, significantly outpacing the industry average of -0.8%. The company reported a net income of CNY 73.41 million for the first half of 2025, up from CNY 51.84 million last year, alongside sales rising to CNY 627.53 million from CNY 532.2 million previously. Despite a volatile share price recently, Bide has repurchased shares worth CNY 99.99 million this year, reflecting confidence in its valuation and future prospects as it forecasts annual earnings growth at 21.28%.</p>
<div class="lb-trans"><p>毕得医药最近的表现突显了其在制药行业的强劲地位，过去一年盈利增长 79.1%，显著超过行业平均的-0.8%。该公司报告 2025 年上半年净收入为 7341 万人民币，较去年 5184 万人民币有所上升，同时销售额从 532.2 百万人民币上升至 627.53 百万人民币。尽管近期股价波动，毕得今年回购了价值 9999 万人民币的股份，反映出对其估值和未来前景的信心，预计年盈利增长为 21.28%。</p>
</div><ul>
<li>Dive into the specifics of Bide Pharmatech here with our thorough health report.</li>
<li>Gain insights into Bide Pharmatech's past trends and performance with our Past report.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里深入了解毕得医药的具体情况，查看我们的详细健康报告。</li>
<li>通过我们的历史报告获取毕得医药的过去趋势和表现的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/dd89aae6-cc4a-4bcd-a11f-dd1dfa24ee7b/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/dd89aae6-cc4a-4bcd-a11f-dd1dfa24ee7b/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:688073 Earnings and Revenue Growth as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 SHSE:688073 盈利和收入增长</p>
</div><h2>Seize The Opportunity</h2>
<div class="lb-trans"><h2>抓住机会</h2>
</div><ul>
<li>Click this link to deep-dive into the 2402 companies within our Asian Undiscovered Gems With Strong Fundamentals screener.</li>
<li>Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.</li>
<li>Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击此链接深入了解我们亚洲未被发现的基本面强劲的 2402 家公司。</li>
<li>这些公司中有哪一些是你资产组合的一部分吗？利用 Simply Wall St 的投资组合分析能力，全面了解它们的发展情况。</li>
<li>Simply Wall St 是你解锁全球市场趋势的关键，是一款面向前瞻性投资者的免费用户友好应用程序。</li>
</ul>
</div><h2>Interested In Other Possibilities?</h2>
<div class="lb-trans"><h2>对其他可能性感兴趣吗？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实你的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑你的目标或财务状况。我们的目标是为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

探索 2025 年 9 月亚洲未被发现的珍宝